Company Hofseth BioCare ASA

Equities

HBC

NO0010598683

Food Processing

Market Closed - Oslo Bors 15:45:00 26/04/2024 BST 5-day change 1st Jan Change
2.09 NOK -0.48% Intraday chart for Hofseth BioCare ASA -2.79% -20.23%

Business Summary

Hofseth Biocare ASA is a Norway-based biotech company that offers ingredients and finished products for humans and animals. The Company’s business is development, manufacturing, marketing and sale of marine ingredients such as oil, calcium and protein products. Its main products are Salmon protein hydrolysate (ProGo), which is a protein for sports, endurance, and recovery powders; Fresh, all-natural salmon oil (OmeGo) that has a full spectrum of omega fatty acids, including EPA, DHA and DPA, totaling 21 different fatty acids; Calcium bone powder (CalGo) is a natural marine collagenic bone powder and CollaGo is a Collagen Peptide powder optimised to improve the beauty of hair, skin and nails. Hofseth BioCare's headquarters are in Aalesund with branches in Oslo, Chicago, Mumbai, Tokyo and Menlo Park, California.

Number of employees: 70

Sales per Business

NOK in Million2022Weight2023Weight Delta
Salmon Oil (OmeGo)
59.3 %
78 64.6 % 129 59.3 % +66.50%
Non-soluble Protein (PetGo)
15.2 %
25 21.2 % 33 15.2 % +30.51%
Reconciling Items
12.3 %
- - 27 12.3 % -
Soluble Protein Hydrolysate (ProGo)
10.9 %
13 10.5 % 24 10.9 % +89.72%
Calcium (CalGo)
1.2 %
3 2.4 % 3 1.2 % -10.67%
Other
1.1 %
2 1.4 % 2 1.1 % +40.66%

Sales per region

NOK in Million2022Weight2023Weight Delta
United States
24.3 %
-- 47 24.3 % -
France
21.1 %
-- 40 21.1 % -
Belgium
13.8 %
-- 26 13.8 % -
Europe excluding Norway, United Kingdom, France, Belgium
13.1 %
78 64.9 % 25 13.1 % -67.95%
United Kingdom
10.4 %
-- 20 10.4 % -
Japan
9.6 %
-- 18 9.6 % -
Norway
4.7 %
7 5.8 % 9 4.7 % +30.11%
Asia excluding Japan
3.0 %
14 11.8 % 6 3.0 % -59.23%

Managers

Managers TitleAgeSince
Chief Executive Officer 51 28/02/13
Chief Executive Officer 50 31/12/99
Chief Tech/Sci/R&D Officer - -
Chief Tech/Sci/R&D Officer 63 31/12/09
Investor Relations Contact - -
Corporate Officer/Principal - 31/12/20
Sales & Marketing - 30/08/14

Members of the board

Members of the board TitleAgeSince
Chief Executive Officer 50 31/12/99
Director/Board Member 53 30/04/15
Director/Board Member 49 30/04/15
Director/Board Member - 02/12/21
Chief Tech/Sci/R&D Officer - -

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 395,081,030 165,069,381 ( 41.78 %) 0 41.78 %

Shareholders

NameEquities%Valuation
128,476,755 32.52 % 25 M kr
40,951,333 10.37 % 8 M kr
Bonafide Wealth Management AG (Liechtenstein)
5.960 %
23,548,260 5.960 % 5 M kr
22,450,000 5.682 % 4 M kr
Brilliant Invest AS
2.784 %
11,000,000 2.784 % 2 M kr
4,053,137 1.026 % 781 364 kr
3,253,370 0.8235 % 627 185 kr
2,964,039 0.7502 % 571 407 kr
750,000 0.1898 % 144 585 kr
700,000 0.1772 % 134 946 kr

Company contact information

Hofseth Biocare ASA

Keiser Wilhelms gate 24

6003, Ålesund

+47 73 10 22 00

http://www.hofsethbiocare.com
address Hofseth BioCare ASA(HBC)
  1. Stock Market
  2. Equities
  3. HBC Stock
  4. Company Hofseth BioCare ASA